Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Holdings Decreased by Legal & General Group Plc
Legal & General Group Plc cut its position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 4.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 232,654 shares of the biotechnology company’s stock after selling 10,867 shares during the quarter. Legal […]
